Stoner G L, Mshana R N, Touw J, Belehu A
Scand J Immunol. 1982 Jan;15(1):33-48. doi: 10.1111/j.1365-3083.1982.tb00619.x.
Sixteen healthy siblings were identified as HLA-D-identical to 12 borderline lepromatous or polar lepromatous leprosy patients by the absence of a mixed lymphocyte reaction (MLR). The peripheral blood mononuclear cells (PBM) of the healthy siblings showed a lymphoproliferative response (delta cpm) to Mycobacterium leprae antigens which was about fivefold or more greater than that of the lepromatous patients. Lepromatous PBM, with or without mitomycin C treatment, were co-cultured with a constant number of normal PBM. In other experiments the two cell types were co-cultured in various proportions, with the total cell number kept constant. Neither approach revealed suppressor cells in lepromatous PBM capable of suppressing the lymphoproliferative response to M. leprae. On the contrary, we found that lepromatous PBM can respond to M. leprae antigens if the sensitized lymphocyte is provided by mitomycin-C treated normal PBM. Additionally, experiments in which isolated adherent cells and non-adherent cells of sibling pairs were recombined failed to reveal a defect in the M. leprae antigen-presenting function of lepromatous adherent cells. Since we found no evidence that sensitized cells are present in lepromatous PBM with their function unexpressed (due to a monocyte defect) or suppressed (due to suppressor cells), we conclude that lepromatous patients simply lack sufficient numbers of antigen-specific T lymphocytes to initiate a lymphoproliferative response to M. leprae antigens. The reason for their absence remains an important unanswered question.
通过混合淋巴细胞反应(MLR)阴性,确定了16名健康同胞与12例界线类偏瘤型或瘤型麻风患者的HLA - D相同。健康同胞的外周血单核细胞(PBM)对麻风杆菌抗原表现出淋巴细胞增殖反应(δ cpm),该反应比瘤型患者的反应大约高五倍或更多。将瘤型PBM(无论是否用丝裂霉素C处理)与恒定数量的正常PBM共培养。在其他实验中,将两种细胞类型按不同比例共培养,总细胞数保持恒定。两种方法均未在瘤型PBM中发现能够抑制对麻风杆菌淋巴细胞增殖反应的抑制细胞。相反,我们发现,如果由丝裂霉素C处理的正常PBM提供致敏淋巴细胞,瘤型PBM可以对麻风杆菌抗原作出反应。此外,对同胞对的分离贴壁细胞和非贴壁细胞进行重组的实验未能揭示瘤型贴壁细胞在麻风杆菌抗原呈递功能方面的缺陷。由于我们没有发现证据表明瘤型PBM中存在功能未表达(由于单核细胞缺陷)或受抑制(由于抑制细胞)的致敏细胞,我们得出结论,瘤型患者只是缺乏足够数量的抗原特异性T淋巴细胞来启动对麻风杆菌抗原的淋巴细胞增殖反应。它们缺失的原因仍然是一个重要的未解决问题。